Phaidon International have been acknowledge as a key partner by BioNTech, the German-based biotechnology company who was the first to bring a successful vaccine against Covid-19 to market. Phaidon International’s life sciences recruitment brand EPM Scientific has been working with BioNTech for a number of years and were pleased to be part of their journey in developing a vaccine.
Harry Youtan, CEO of Phaidon International says: “Often we spend time focusing on the day to day tasks, but on this occasion more than perhaps others, everyone in our team is extraordinarily proud that we are helping, in our own way, to overcome one of the greatest challenges in recent times.”
“Despite the damage caused by the virus, I have been inspired each day by the spirit of collaboration and scientific discovery,” said Ugur Sahin, CEO and co-founder of BioNTech. “It is one of the greatest honours of my life to be involved in this effort and to play a role in helping the world regain a sense of normality. I would like to thank each and every person that helped make this a reality.”